Palo Alto, California (PRWEB) December 11, 2015
Glooko Inc. announced that is has been recognized by this year’s Fierce Innovation Awards: Healthcare Edition, a unique awards program from the publishers of FierceHealthIT, FierceHealthcare, and FierceMobileHealthcare. Glooko received top honors in the Population Health Management/Patient Engagement Solutions category, as well as an overall award of “Best in Show: “Fiercest New Product/Service.”
The Fierce Innovation Awards recognize pioneering technologies and solutions that will catapult healthcare delivery into exciting new realms. Winners were selected by a distinguished panel of CIOs from renowned U.S. hospitals and healthcare systems, including Allina Health, Rush University Medical Center, Aspirus, and JFK Health System, among others. A complete list of judges can be found at https://www.fierceinnovationawards.com/healthit/2015#our_judges.
All applications were evaluated based on the following criteria: care efficiency, competitive advantage, financial impact/value, market need, patient experience/satisfaction, quality of care and patient outcomes, and overall fierceness and innovation. Finalists were selected based on calculation of the judges’ scores in each area.
Glooko is being recognized for its innovative, industry-leading diabetes population management and remote monitoring platform. The platform unifies data from over 50 of the leading blood glucose meters, insulin pumps, continuous glucose monitors and biometric devices to deliver insights that improve personal diabetes care and clinical decision support.
To learn more about Glooko, visit http://www.glooko.com.
FierceMarkets, a division of Questex, LLC, is a leader in B2B e-media, providing information and marketing services in the telecommunications, life sciences, healthcare and technology industries through its portfolio of email newsletters, websites, webinars and live events. Every business day, FierceMarkets' wide array of digital publications reaches more than 2 million executives in more than 100 countries.
Current publications include: Telecom: FierceWireless; FierceCable; FierceDeveloper; FierceOnlineVideo; FierceTelecom; FierceWirelessTech; FierceWireless:Europe /TelecomsEMEA, FierceInstaller; Smart Grid News; and Telecom Asia; Healthcare: FierceEMR; FierceHealthcare; FierceHealthFinance; FierceHealthIT; FierceHealthPayer; FierceHealthPayerAntiFraud; FierceMobileHealthcare; FiercePracticeManagement and Hospital Impact; Life Sciences: FierceAnimalHealth; FierceBiotech; FierceBiotechIT; FierceBiotechResearch; FierceCRO; FierceDiagnostics, FierceDrugDelivery; FierceMedicalDevices; FiercePharma; FiercePharmaAsia; FiercePharmaMarketing; FiercePharmaManufacturing; and FierceVaccines; Technology: FierceBigData; FierceCIO; FierceCities; FierceContentManagement; FierceDevOps; FierceEnterpriseCommunications; FierceFinanceIT; FierceGovernmentIT; FierceITSecurity; FierceMobileIT; ; FierceCMO; and FierceRetail.
Glooko is the Unified Platform for Diabetes Management and provides an FDA-cleared, HIPAA-compliant Web and Mobile application for diabetes patients and clinicians which improves outcomes and lowers costs. The platform seamlessly unifies data from over 50 of the leading blood glucose meters, insulin pumps, continuous glucose monitors, activity trackers and biometric devices to deliver insights that improve personal and clinical decision support. Glooko’s mobile app enables patients to easily track and proactively manage all aspects of their diabetes care. Glooko’s population management web app and API’s offers diabetes-centric analytics and supplies insightful reports, graphs and pattern-triggered notifications to patients, health systems and payers. The Glooko platform also allows customers and third party developers to create branded modules for Glooko users. Learn more at http://www.glooko.com and follow us at https://www.twitter.com/GlookoInc, and https://www.facebook.com/Glooko